Skip to main content

High 68 Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma

This is a preview of subscription content, access via your institution.


  1. 1.

    Mukhopadhyay S, Wilcox BE, Myers JL, Bryant SC, Buckwalter SP, Wengenack NL, et al. Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest. 2013;144:813–24.

    Article  Google Scholar 

  2. 2.

    Thiessen R, Seely JM, Matzinger FR, Agarwal P, Burns KL, Dennie CJ, et al. Necrotizing granuloma of the lung: imaging characteristics and imaging-guided diagnosis. AJR Am J Roentgenol. 2007;189:1397–401.

    Article  Google Scholar 

  3. 3.

    Aubry MC. Necrotizing granulomatous inflammation: what does it mean if your special stains are negative? Mod Pathol. 2012;25(Suppl 1):S31–8.

    Article  Google Scholar 

  4. 4.

    Hunninghake GW, Garrett KC, Richerson HB, Fantone JC, Ward PA, Rennard SI, et al. Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis. 1984;130:476–96.

    CAS  PubMed  Google Scholar 

  5. 5.

    Chen H, Zhao L, Ruan D, Pang Y, Hao B, Dai Y, et al. Usefulness of [(68)Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [(18)F]FDG PET/CT findings. Eur J Nucl Med Mol Imaging. 2021;48:73–86.

    Article  Google Scholar 

  6. 6.

    Hao B, Wu X, Pang Y, Sun L, Wu H, Huang W, et al. [(18)F]FDG and ([68)Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of tuberculous lesions. Eur J Nucl Med Mol Imaging. 2021;48:651–2.

    Article  Google Scholar 

Download references


The study was partially funded by the ERF-SNMMI (2019–2021 Molecular Imaging Research Grant for Junior Academic Faculty).

Author information



Corresponding author

Correspondence to Masatoshi Hotta.

Ethics declarations

Conflict of interest

Jeremie Calais is the recipient of grants from the ERF-SNMMI (2019–2021 Molecular Imaging Research Grant for Junior Academic Faculty), the Philippe Foundation Inc. (NY, USA), and the ARC Foundation (France) (International Mobility Award SAE20160604150). Jeremie Calais is a consultant for Blue Earth Diagnostics, Curium Pharma, GE Healthcare, Janssen Pharmaceuticals, Progenics Radiopharmaceuticals, Radiomedix, and Telix Pharmaceuticals, outside of the submitted work. All other co-authors have no conflict of interest.

Ethics approval

All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Written and oral informed consent was provided by the patient involved in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Infection and inflammation

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hotta, M., Benz, M.R., Allen-Auerbach, M.S. et al. High 68 Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma. Eur J Nucl Med Mol Imaging (2021).

Download citation